Noblelife Pharmaceuticals (I) Private Limited - Company Profile

It is a chemicals private limited company based in Gorakhpur, Uttar Pradesh, India, established in 2022.

2022 Gorakhpur, Uttar Pradesh, India Active

Last Updated: February 26, 2026

About Noblelife Pharmaceuticals (I) Private Limited

Noblelife Pharmaceuticals (I) Private Limited, a active private limited company, was established on 12 October 2022 in Gorakhpur, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239UP2022PTC172052. Registered under ROC Roc Uttar Pradesh I. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.15 M.

Its leadership includes Akhilesh Tripathi (Director), Singh Ranjit Ramdev (Director). Past directors included Sushil Pandey. It is based at C/O Sumati Singh Jungle Sikari, Gorakhpur, Uttar Pradesh, 273008.

Company Details

CIN/LLPIN
U24239UP2022PTC172052
Registration Number
172052
Incorporation Date
12 October 2022
Authorized Capital
₹1.50 M
Paid-Up Capital
₹0.15 M
ROC Code
Roc Uttar Pradesh I
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.50 M as on 26-02-2026
Paid Up Capital ₹ 0.15 M as on 26-02-2026
Company Age 3 Year, 4 Months

Comprehensive Company Insights

Explore comprehensive insights into Noblelife Pharmaceuticals (I) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Noblelife Pharmaceuticals (I) Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Akhilesh Tripathi	Director	12 Oct 2022	Current
Singh Ranjit Ramdev	Director	31 Jul 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	02 Aug 2023	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Noblelife Pharmaceuticals (I).

Enhance accessibility to Noblelife Pharmaceuticals (I)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Noblelife Pharmaceuticals (I)?

Unlock access to Noblelife Pharmaceuticals (I)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Noblelife Pharmaceuticals (I)?

Noblelife Pharmaceuticals (I) has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Noblelife Pharmaceuticals (I), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noblelife Pharmaceuticals (I)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Noblelife Pharmaceuticals (I)

Recent Activity within the Organization

Director Appointment

Progress on Singh Ranjit Ramdev was appointed as a Director was appointed as a Director on 31 Jul 2023 & has been associated with this company since 2 years 7 months . was documented.
31 Jul 2023
Director Appointment

The activity Akhilesh Tripathi was appointed as a Director was appointed as a Director on 12 Oct 2022 & has been associated with this company since 3 years 4 months . was completed.
12 Oct 2022
Company Incorporation

The activity Noblelife Pharmaceuticals (I) Private Limited was registered on 12 Oct 2022 with Roc Uttar Pradesh I & aged 3 years 4 months as per MCA records. was completed.
12 Oct 2022

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Noblelife Pharmaceuticals (I) Private Limited?

The CIN of Noblelife Pharmaceuticals (I) Private Limited is U24239UP2022PTC172052.

Where is Noblelife Pharmaceuticals (I) Private Limited headquartered?

Noblelife Pharmaceuticals (I) Private Limited is headquartered at C/O Sumati Singh Jungle Sikari, Gorakhpur, Uttar Pradesh, 273008.

When was Noblelife Pharmaceuticals (I) Private Limited incorporated?

Noblelife Pharmaceuticals (I) Private Limited was incorporated on 12 October 2022.

Who are the current directors of Noblelife Pharmaceuticals (I) Private Limited?

The current directors of Noblelife Pharmaceuticals (I) Private Limited are

What is the primary industry of Noblelife Pharmaceuticals (I) Private Limited?

The primary industry of Noblelife Pharmaceuticals (I) Private Limited is Chemicals.

Is Noblelife Pharmaceuticals (I) Private Limited a listed company?

Noblelife Pharmaceuticals (I) Private Limited is unlisted.

What is the capital structure of Noblelife Pharmaceuticals (I) Private Limited?

The authorized capital of Noblelife Pharmaceuticals (I) Private Limited is ₹1.50 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available